LIGAND PHARMACEUTICALS INC - Common Stock (LGND)

CUSIP: 53220K504

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock
Shares outstanding
19,667,509
Total 13F shares
18,695,299
Share change
+445,540
Total reported value
$1,968,273,762
Put/Call ratio
86%
Price per share
$105.14
Number of holders
258
Value change
+$46,599,577
Number of buys
130
Number of sells
112

Quarterly Holders Quick Answers

What is CUSIP 53220K504?
CUSIP 53220K504 identifies LGND - LIGAND PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q1 2025

As of 31 Mar 2025, LIGAND PHARMACEUTICALS INC - Common Stock (LGND) was held by 258 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,695,299 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, MACQUARIE GROUP LTD, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, CONGRESS ASSET MANAGEMENT CO, Stephens Investment Management Group LLC, Chicago Capital, LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 257 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.